Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate'
BioCryst to buy Astria Therapeutics in $700 million deal